Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia

Pathology Research and Practice

Volumn 205, Issue 5, 2009, Pages 331-337

  Nishio, Shin ^a,b   Tsuda, Hitoshi ^a,c   Fujiyoshi, Naoki ^b   Ota, Shun Ichiro ^b   Ushijima, Kimio ^b   Sasajima, Yuko ^c   Kasamatsu, Takahiro ^c   Kamura, Toshiharu ^b   Matsubara, Osamu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cervical adenocarcinoma; LEGH; Prognostic factor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; STOMACH MUCIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORPHOLOGY; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 64449084374     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.12.002     Document Type: Article

References (19)

1. Caminski P.F., and Norris H.J. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int. J. Gynecol. Pathol. 2 (1983) 141-152
2. Gilks C.B., Young R.H., Aguire P., DeLellis R.A., and Scully R.E. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunochemical analysis of 26 cases. Am. J. Surg. Pathol. 13 (1989) 717-729
3. Gusserow A.L.S. Über sarcome des uterus. Arch. J. Gynaekol. 1 (1870) 240-251
4. Hashi A., Xu J.Y., Kondo T., Hashi K., Yuminamochi T., Nara M., Murata S., Katoh R., and Hoshi K. p16INK4a Overexpression independent of human papillomavirus infection in lobular endcervical glandular hyperplasia. Int. J. Gynecol. Pathol. 25 (2006) 187-194
5. Hayashi I., Tsuda H., Shimoda T., Maeshima A., Kasamatsu T., Yamada T., and Tsunematsu R. Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix. Virchows Arch. 443 (2003) 752-760
6. Ishii K., Hosaka N., Toki T., Momose M., Hidaka E., Tsuchiya S., and Katsuyama T. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 432 (1998) 315-322
7. Ishii K., Katsuyama T., Ota H., Watanabe T., Matsuyama I., Tsuchiya S., Shiozawa T., and Toki T. Cytologic and cytochemical features of adenoma malignum of the uterine cervix. Cancer 87 (1999) 245-253
8. Kondo T., Hashi A., Murata S., Nakazawa T., Yuminamochi T., Nara M., Hoshi K., and Katoh R. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod. Pathol. 18 (2005) 1199-1210
9. Mikami Y., Hata S., Melamed J., and Fujiwara K. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 39 (2001) 364-372
10. Mikami Y., Kiyokawa T., Hata S., Fujiwara K., Moriya T., Sasano H., Manabe T., Akahira J., Ito K., Tase T., Yaegashi N., Sato I., Tateno H., and Naganuma H. Gastrointestinal immunophenotype in adenocarcinoma of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod. Pathol. 17 (2004) 962-972
11. Mikami Y., Kiyokawa T., Moriya T., and Sasano H. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma (adenoma malignum) and endocervical glandular hyperplasia: a study using oestrogen receptor and α-smooth muscle actin double immunostaining. Histopathology 46 (2005) 130-136
12. Missaoui N., Hmissa S., Frappart L., Trabelsi A., Ben Abdelkader A., Traore C., Mokni M., Yaecoubi M.T., and Korbi S. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch. 448 (2006) 597-603
13. Nucci M.R., Clement P.B., and Young R.H. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am. J. Surg. Pathol. 23 (1999) 866-891
14. Sasajima Y., Mikami Y., Kaku T., Kiyokawa T., Ohishi Y., Hamada T., Sasaki T., Fujita H., Moriya T., Kasamatsu T., and Tsuda H. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib adenocarcinoma of the uterine cervix. Histopathology 53 (2008) 487-490
15. Silverberg S.G., and Hurt G. Minimal deviation adenocarcinoma (adenoma malignum) of the cervix. A reappraisal. Am. J. Obstet. Gynecol. 121 (1975) 971-975
16. Tsuda H., Mikami Y., Kaku T., Akiyama F., Hasegawa T., Okada S., Hayashi I., and Kasamatsu T. Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. Pathol. Int. 53 (2003) 440-449
17. Tsuda H., Mikami Y., Kaku T., Hasegawa T., Akiyama F., Ohishi Y., Sasajima Y., and Kasamatsu T. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria. Pathol. Int. 55 (2005) 412-418
18. Utsugi K., Hirai Y., Takeshima N., Akiyama F., Sakurai S., and Hasumi K. Utility of the monoclonal antibody HIK1083 in the diagnosis of the adenoma malignum of the uterine cervix. Gynecol. Oncol. 75 (1999) 345-348
19. Xu J.Y., Hashi A., Kondo T., Yuminamochi T., Nara M., and Hashi K. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int. J. Gynecol. Pathol. 24 (2005) 296-302